Literature DB >> 18181248

Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.

Anne K Callesen1, René dePont Christensen, Jonna S Madsen, Werner Vach, Edgar Zapico, Søren Cold, Per E Jørgensen, Ole Mogensen, Torben A Kruse, Ole N Jensen.   

Abstract

Protein profiling of human serum by matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) is potentially a new diagnostic tool for early detection of human diseases, including cancer. Sample preparation is a key issue in MALDI MS and the analysis of complex samples such as serum requires optimized, reproducible methods for handling and deposition of protein samples. Data acquisition in MALDI MS is also a critical issue, since heterogeneity of sample deposits leads to attenuation of ion signals in MALDI MS. In order to improve the robustness and reproducibility of MALDI MS for serum protein profiling we investigated a range of sample preparation techniques and developed a statistical method based on repeated analyses for evaluation of protein-profiling performance of MALDI MS. Two different solid-phase extraction (SPE) methods were investigated, namely custom-made microcolumns and commercially available magnetic beads. Using these two methods, nineteen different sample preparation methods for serum profiling by MALDI MS were systematically tested with regard to matrix selection, stationary phase, selectivity, and reproducibility. Microcolumns were tested with regard to chromatographic properties; reversed phase (C8, C18, SDB-XC), ion-exchange (anion, weak cation, mixed-phase (SDB-RPS)) and magnetic beads were tested with regard to chromatographic properties; reversed phase (C8) or affinity chromatography (Cu-IMAC). The reproducibility of each sample preparation method was determined by enumeration and analysis of protein signals that were detected in at least six out of nine spectra obtained by three triplicate analyses of one serum sample.A candidate for best overall performance as evaluated by the number of peaks generated and the reproducibility of mass spectra was found among the tested methods. Up to 418 reproducible peaks were detected in one cancer serum sample. These protein peaks can be part of a possible diagnostic profile, suggesting that this sample preparation method and data acquisition approach is suitable for large-scale analysis of serum samples for protein profiling. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181248     DOI: 10.1002/rcm.3364

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  7 in total

1.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

Review 2.  Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Authors:  Fulvio Magni; Yuri E M Van Der Burgt; Clizia Chinello; Veronica Mainini; Erica Gianazza; Valeria Squeo; André M Deelder; Marzia Galli Kienle
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Authors:  L Chung; S Shibli; K Moore; E E Elder; F M Boyle; D J Marsh; R C Baxter
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

4.  MALDI profiling of human lung cancer subtypes.

Authors:  Angelo Gámez-Pozo; Iker Sánchez-Navarro; Manuel Nistal; Enrique Calvo; Rosario Madero; Esther Díaz; Emilio Camafeita; Javier de Castro; Juan Antonio López; Manuel González-Barón; Enrique Espinosa; Juan Angel Fresno Vara
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

Review 5.  The proteomics big challenge for biomarkers and new drug-targets discovery.

Authors:  Rocco Savino; Sergio Paduano; Mariaimmacolata Preianò; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

6.  An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis.

Authors:  Claudia Boccardi; Silvia Rocchiccioli; Antonella Cecchettini; Alberto Mercatanti; Lorenzo Citti
Journal:  BMC Res Notes       Date:  2012-11-01

7.  Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.

Authors:  Lucas Cardoso Lazari; Fabio De Rose Ghilardi; Livia Rosa-Fernandes; Diego M Assis; José Carlos Nicolau; Veronica Feijoli Santiago; Talia Falcão Dalçóquio; Claudia B Angeli; Adriadne Justi Bertolin; Claudio Rf Marinho; Carsten Wrenger; Edison Luiz Durigon; Rinaldo Focaccia Siciliano; Giuseppe Palmisano
Journal:  Life Sci Alliance       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.